drugset
drugset / Trial / NCT05043792

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dose of TT-00920 in Healthy Subjects

NCT05043792 ↗

Phase 1 Completed 20 enrolled TransThera Sciences (Nanjing), Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a double-blind, randomized, placebo-controlled, multiple ascending dose escalation study of TT-00920 in healthy subjects.

Timeline

Start
2021-08-19
Primary completion
2021-11-30
Completion
2021-11-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator TT-00920 Unknown — Oral

Indications

No indication recorded.